MedPath
FDA Approval

Alfuzosin hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 19, 2017
Labeling Type
Human Prescription Drug Label
Alfuzosin(10 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aphena Pharma Solutions - Tennessee, LLC

Aphena Pharma Solutions - Tennessee, LLC

128385585

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Alfuzosin hydrochloride

Product Details

NDC Product Code
43353-945
Application Number
ANDA090284
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 22, 2014
GUAR GUMInactive
Code: E89I1637KEClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
AlfuzosinActive
Code: 75046A1XTNClass: ACTIBQuantity: 10 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath